Integra LifeSciences Holdings Corp. (IART)
14.05
+0.39
(+2.86%)
USD |
NASDAQ |
Dec 11, 16:00
14.04
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Research and Development Expense (Quarterly): 20.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Masimo Corp. | 30.50M |
| LeMaitre Vascular, Inc. | 2.97M |
| Clearpoint Neuro, Inc. | 3.452M |
| Tandem Diabetes Care, Inc. | 47.88M |
| iRhythm Technologies, Inc. | 21.03M |